Triggering cell death in metastatic melanoma may pave the way for new cancer treatments

Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor protein 1 (FSP1)—a surprising metabolic dependency that could open the door to a new class of cancer treatments, according to a new study led by Harvard T.H. Chan School of Public Health.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup